Undifferentiated Carcinoma of Larynx of Nasopharyngeal Type

Undifferentiated carcinoma of nasopharyngeal type arising in the larynx is unusual. This type of carcinoma-which occurs almost exclusively in nasopharynx-is very infrequent in the larynx (0.2%). Till date only 17 cases are reported in the medical literature. We present the clinical and histopathological findings along with the management of one additional case of undifferentiated carcinoma of nasopharyngeal type in the larynx which was managed successfully with radiotherapy

LATS2 is De-methylated and Overexpressed in Nasopharyngeal Carcinoma and Predicts Poor Prognosis

<p>Abstract</p> <p>Background</p> <p>LATS2, which encodes a novel serine/threonine kinase, is known to be important in centrosome duplication and in the maintenance of genomic stability. Recently, a potential role for LATS2 in cancer has been reported. In breast cancer and acute lymphoblastic leukemia (ALL), LATS2 mRNA is downregulated and has been suggested to be a tumor suppressor. However, the role of LATS2 in nasopharyngeal carcinoma has not been investigated. In this study, we aimed to investigate the expression pattern of LATS2 and its clinicopathological involvement in nasopharyngeal carcinoma to understand its effect on cell survival.</p> <p>Methods</p> <p>Using quantitative real time PCR and immunoblotting, the expression of LATS2 was detected in nasopharyngeal carcinoma cell lines and in the immortalized nasopharyngeal epithelial cell line NP69. Using immunohistochemistry, we analyzed LATS2 protein expression in 220 nasopharyngeal carcinoma cases. The association of LATS2 protein expression with the clinicopathological characteristics and the prognosis of nasopharyngeal carcinoma were subsequently assessed. Using methylation specific PCR, we detected the methylation status of the LATS2 promoter. RNA interference was performed by transfecting siRNA to specifically knock down LATS2 expression in 5-8F and CNE2.</p> <p>Results</p> <p>LATS2 protein was detected in 178 of 220 (80.91%) cases of nasopharyngeal carcinoma. LATS2 overexpression was a significant, independent prognosis predictor (<it>P </it>= 0.037) in nasopharyngeal carcinoma patients. Methylation specific PCR revealed that 36.7% (11/30) of nasopharyngeal carcinoma tissues and all of the chronic nasopharyngeal inflammation samples were methylated. Functional studies showed that the suppression of LATS2 expression in nasopharyngeal carcinoma (5-8F and CNE2) cell lines by using specific small interfering (siRNA) resulted in the inhibition of growth, induction of apoptosis and S-phase cell cycle increase. Overexpression of LATS2 in NP69 stimulated cell proliferation.</p> <p>Conclusions</p> <p>Our results indicate that LATS2 might play a role in the tumorigenesis of nasopharyngeal carcinoma by promoting the growth of nasopharyngeal carcinoma cells. Transfection with specific siRNA might be feasible for the inhibition of growth, induction of apoptosis and S phase increase in nasopharyngeal carcinoma.</p

Distribusi Keganasan Nasofaring Berdasarkan Pemeriksaan Histopatologi pada Rumah Sakit di Kota Pekanbaru Tahun 2009-2013

Nasopharyngeal carcinoma is a Malignant tumor derived from epithelial cells in the nasopharynx. The rates of nasopharyngeal carcinoma has increased in the region of the head and neck. In 2010, nasopharyngeal carcinoma ranks 5th out of 10th. This study is descriptive with retrospective design that aimed to determine the distribution of nasopharyngeal carcinoma at hospitals in Pekanbaru from 2009-2013. The data collected from anatomical pathology laboratory center and hospitals in Pekanbaru, including: gender, age, histopathologic types and occupation. The result showed that there was 199 cases of nasopharyngeal carcinoma with the highest case found in 2013 were 92 (24,6%). The highest case found in Arifin Achmad Hospital were 92 (46,2%) and the lowest rates was in the Army hospital and Bhayangkara with 1 (0.5%) case. Nasopharyngeal carcinoma mostly infected male 130 (65,3%) cases than female 69 (34,7%) cases. The age range of 45-54 years had 56 (28.1%) cases. Most of histopathologic types had found in the type of undifferentiated carcinoma (WHO type III) as many as 136 (68,3%) cases. The most occupation is farmer and housewifes as many as 32 (16.1%) cases

Unique case of inverted papilloma of septum with nasopharyngeal carcinoma:Is it a metachronous tumour?

Inverted papilloma is a rare and benign tumour. It affects the nasal cavity and paranasal sinuses, has a high rate of recurrence and is associated with malignant transformation. Only few cases of a poorly differentiated carcinoma arising from inverted papilloma have been reported, none of which in the nasopharynx. We report a case of a 37-year-old female, who presented originally in 2012 with inverted papilloma of the nasal septum which was surgically resected. Nasopharyngeal biopsy from 2014 was reported as carcinoma in situ and treated with local endoscopic resection. Three years later she presented with a solitary lesion of the right Eustachian tube opening, confirmed as invasive poorly differentiated carcinoma. Imaging revealed T4 N2b M0 malignancy with skull base and prevertebral space invasion, likely extension into right temporal lobe and malignant adenopathy. Although rare, malignant transformation of inverted papilloma in unusual places should be considered during workup and monitoring of patients

MiR-646 targets PDK1 to recede aerobic glycolysis and cell proliferation in nasopharyngeal carcinoma

Purpose: To investigate the effect and mechanism of miR-646 on aerobic glycolysis and cell proliferation in nasopharyngeal carcinoma. Methods: MiR-646 expression in human nasopharyngeal carcinoma cell lines was determined by quantitative real-time polymerase chain reaction) (qRT-PCR). Cell counting kit-8 (CCK8) was used to evaluate cell viability, and colony formation assay was also performed. The target of miR-646 was determined by luciferase activity assay. The effect of miR-646 on aerobic glycolysis was assessed via glucose uptake, and lactate and ATP production. Western blot analysis was conducted to unravel the underlying mechanism involved in the regulation of miR-646 in nasopharyngeal carcinoma. Results: MiR-646 was downregulated in human nasopharyngeal carcinoma cell lines. MiR-646 mimics decreased cell viability and inhibited cell proliferation, whereas miR-646 inhibitor increased cell viability and promoted cell proliferation. Pyruvate dehydrogenase kinase 1(PDK1) was identified as a target of miR-646, and its expression was negatively regulated by miR-646. MiR-646 probably inhibited aerobic glycolysis via regulation of PDK1, as shown by decreased glucose uptake and decreased lactate and ATP production. The inhibitory effect of miR-646 on nasopharyngeal carcinoma cell proliferation was partly via PDK1 regulation. Conclusion: MiR-646 inhibits aerobic glycolysis in nasopharyngeal carcinoma and promotes cell proliferation via suppression of PDK1, suggesting miR-646 as a potential therapeutic target in nasopharyngeal carcinoma